These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25174607)

  • 41. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling.
    Skvortsova I; Debbage P; Kumar V; Skvortsov S
    Semin Cancer Biol; 2015 Dec; 35():39-44. PubMed ID: 26392376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells.
    Alotaibi M; Sharma K; Saleh T; Povirk LF; Hendrickson EA; Gewirtz DA
    Radiat Res; 2016 Mar; 185(3):229-45. PubMed ID: 26934368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosensitization of EMT6 mammary carcinoma cells by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide.
    Haykal J; Fernainy P; Itani W; Haddadin M; Geara F; Smith C; Gali-Muhtasib H
    Radiother Oncol; 2008 Mar; 86(3):412-8. PubMed ID: 18006096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis.
    Wang F; Tang J; Li P; Si S; Yu H; Yang X; Tao J; Lv Q; Gu M; Yang H; Wang Z
    Cell Physiol Biochem; 2018; 45(1):54-66. PubMed ID: 29316551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner.
    Li Q; Hu Y; Xi M; He L; Zhao L; Liu M
    BMC Cancer; 2012 Oct; 12():485. PubMed ID: 23088517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.
    Chiu SJ; Hsaio CH; Tseng HH; Su YH; Shih WL; Lee JW; Chuah JQ
    Biochem Biophys Res Commun; 2010 Apr; 394(3):774-9. PubMed ID: 20227390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
    Zhang Y; Jung M; Dritschilo A; Jung M
    Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WEE1 inhibition sensitizes osteosarcoma to radiotherapy.
    PosthumaDeBoer J; Würdinger T; Graat HC; van Beusechem VW; Helder MN; van Royen BJ; Kaspers GJ
    BMC Cancer; 2011 Apr; 11():156. PubMed ID: 21529352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer.
    Karnak D; Engelke CG; Parsels LA; Kausar T; Wei D; Robertson JR; Marsh KB; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
    Clin Cancer Res; 2014 Oct; 20(19):5085-96. PubMed ID: 25117293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging targets for radioprotection and radiosensitization in radiotherapy.
    Kumar S; Singh RK; Meena R
    Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
    Ghashghaei M; Niazi TM; Heravi M; Bekerat H; Trifiro M; Paliouras M; Muanza T
    Prostate; 2018 Jan; 78(1):64-75. PubMed ID: 29134684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
    Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
    Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction.
    Stingl L; Stühmer T; Chatterjee M; Jensen MR; Flentje M; Djuzenova CS
    Br J Cancer; 2010 May; 102(11):1578-91. PubMed ID: 20502461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.
    Morgan MA; Lawrence TS
    Clin Cancer Res; 2015 Jul; 21(13):2898-904. PubMed ID: 26133775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent developments in radiosensitization.
    Linam J; Yang LX
    Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiosensitization of clioquinol and zinc in human cancer cell lines.
    Lu S; Ke Y; Wu C; Zhong Y; Xie C; Zhou Y; Zhou F; Yu H
    BMC Cancer; 2018 Apr; 18(1):448. PubMed ID: 29678153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation.
    Zhang T; Cui GB; Zhang J; Zhang F; Zhou YA; Jiang T; Li XF
    Oncol Rep; 2010 Dec; 24(6):1683-9. PubMed ID: 21042768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell signalling and radiation survival: the impact of protein phosphatases.
    Hamilton J; Bernhard EJ
    Int J Radiat Biol; 2009 Nov; 85(11):937-42. PubMed ID: 19895270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.